Numbers, percentages and hazard ratios for 180-day mortality in patients without angiography, with angiography and with intervention
| Patients | Deaths (%) | HR1 (95% CI) | HR2 (95% CI) | HR3 (95% CI) | |
| All | |||||
| No angiography | 4296 | 777 (18.1) | 1.00 | 1.00 | 1.00 |
| Angiography only | 2372 | 148 (6.2) | 0.32 (0.27 to 0.39) | 0.60 (0.50 to 0.73) | 0.59 (0.49 to 0.72) |
| With intervention | 4128 | 126 (3.1) | 0.16 (0.13 to 0.19) | 0.33 (0.27 to 0.41) | 0.34 (0.28 to 0.42) |
| Women | |||||
| No angiography | 2030 | 345 (17.0) | 1.00 | 1.00 | 1.00 |
| Angiography only | 841 | 44 (5.2) | 0.29 (0.21 to 0.39) | 0.53 (0.38 to 0.74) | 0.52 (0.37 to 0.73) |
| With intervention | 1051 | 42 (4.0) | 0.22 (0.16 to 0.30) | 0.44 (0.31 to 0.62) | 0.42 (0.29 to 0.60) |
| Men | |||||
| No angiography | 2249 | 428 (19.0) | 1.00 | 1.00 | 1.00 |
| Angiography only | 1526 | 104 (6.8) | 0.34 (0.27 to 0.42) | 0.64 (0.50 to 0.80) | 0.63 (0.50 to 0.80) |
| With intervention | 3059 | 82 (2.7) | 0.13 (0.10 to 0.16) | 0.29 (0.22 to 0.38) | 0.31 (0.24 to 0.41) |
p Value <0.001 for all HRs
HR1, hazard ratio after univariate analysis; HR2, hazard ratio adjusted for age, sex, Asian ethnicity, current smoking, admitting consultant, admission to cardiac facility, deprivation in highest quartile, propensity score; HR3, hazard ratio adjusted as for HR2 plus the following: previous angina, previous myocardial infarction, heart failure, chronic obstructive pulmonary disease, chronic renal failure, peripheral vascular disease, cerebrovascular disease, hypertension, diabetes, treated hyperlipidaemia, discharge drugs: angiotensin converting enzyme inhibitor, β blocker, aspirin, clopidogrel, statin.
Reference; patients not having angiography. Gender was not available for 40 records.